Kalkan, Z.; Ebinc, S.; Arcagok, M.; Bilici, A.; Yildiz, O.; Kilickap, S.; Guven, D.C.; Tatli, A.M.; Sumbul, A.T.; Mandel, N.M.;
et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina 2025, 61, 638.
https://doi.org/10.3390/medicina61040638
AMA Style
Kalkan Z, Ebinc S, Arcagok M, Bilici A, Yildiz O, Kilickap S, Guven DC, Tatli AM, Sumbul AT, Mandel NM,
et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina. 2025; 61(4):638.
https://doi.org/10.3390/medicina61040638
Chicago/Turabian Style
Kalkan, Ziya, Senar Ebinc, Murat Arcagok, Ahmet Bilici, Ozcan Yildiz, Saadettin Kilickap, Deniz Can Guven, Ali Murat Tatli, Ahmet Taner Sumbul, Nil Molinas Mandel,
and et al. 2025. "Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study" Medicina 61, no. 4: 638.
https://doi.org/10.3390/medicina61040638
APA Style
Kalkan, Z., Ebinc, S., Arcagok, M., Bilici, A., Yildiz, O., Kilickap, S., Guven, D. C., Tatli, A. M., Sumbul, A. T., Mandel, N. M., Ozturk, A., Bardakci, M., Karakaya, S., & Kaplan, M. A.
(2025). Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina, 61(4), 638.
https://doi.org/10.3390/medicina61040638
